<?xml version="1.0" encoding="UTF-8"?>
<!-- generated by CLiX/Wiki2XML [MPI-Inf, MMCI@UdS] $LastChangedRevision: 92 $ on 16.04.2009 17:42:51[mciao0825] -->
<!DOCTYPE article SYSTEM "../article.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink">
<entity  confidence="0.9511911446218017" wordnetid="100001740">
<header>
<title>Quantitative structure-activity relationship</title>
<id>826669</id>
<revision>
<id>231525103</id>
<timestamp>2008-08-12T20:30:13Z</timestamp>
<contributor>
<username>CyberScientist</username>
<id>7640664</id>
</contributor>
</revision>
<categories>
<category>Paradoxes</category>
<category>Pharmacology</category>
<category>Medicinal chemistry</category>
<category>Cheminformatics</category>
</categories>
</header>
<bdy>

<b>Quantitative structure-activity relationship (QSAR)</b> is the process by which <link xlink:type="simple" xlink:href="../009/474009.xml">
chemical structure</link> is quantitatively <link xlink:type="simple" xlink:href="../057/157057.xml">
correlated</link> with a well defined process, such as <link xlink:type="simple" xlink:href="../629/4387629.xml">
biological activity</link> or chemical reactivity.<p>

For example, biological activity can be expressed quantitatively as in the concentration of a substance required to give a certain biological response.  Additionally, when physicochemical properties or structures are expressed by numbers, one can form a mathematical relationship, or quantitative structure-activity relationship, between the two.  The mathematical expression can then be used to predict the biological response of other chemical structures.</p>
<p>

QSAR's most general mathematical form is:
<indent level="1">

Activity = <it>f</it>(physiochemical properties and/or structural properties)
</indent>

</p>
<sec>
<st>
SAR and SAR paradox</st>
<p>

The basic assumption for all molecule based <link xlink:type="simple" xlink:href="../281/14281.xml">
hypotheses</link> is that similar molecules have similar activities. This principle is also called <b>S</b>tructure-<b>A</b>ctivity <b>R</b>elationship (SAR). The underlying problem is therefore how to define a <it>small</it> difference on a molecular level, since each kind of activity, e.g. <link xlink:type="simple" xlink:href="../271/6271.xml">
reaction</link> ability, <link xlink:type="simple" xlink:href="../369/11594369.xml">
biotransformation</link> ability, <link xlink:type="simple" xlink:href="../497/59497.xml">
solubility</link>, target activity, and so on, might depend on another difference. A good example was given in the <link xlink:type="simple" xlink:href="../736/5378736.xml">
bioisosterism</link> review of Patanie/LaVoie.<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%221%22])">1</ref></p>
<p>

In general, one is more interested in finding strong <link xlink:type="simple" xlink:href="../154/1360154.xml">
trend</link>s. Created <link xlink:type="simple" xlink:href="../281/14281.xml">
hypotheses</link> usually rely on a <link xlink:type="simple" xlink:href="../742/11742.xml">
finite</link> number of chemical data. Thus, the <link xlink:type="simple" xlink:href="../736/393736.xml">
induction principle</link> should be respected to avoid <link xlink:type="simple" xlink:href="../332/173332.xml">
overfitted</link> hypotheses and deriving overfitted and useless interpretations on structural/molecular data.</p>
<p>

The SAR paradox refers to the fact that it is not the case that all similar molecules have similar activities.</p>

</sec>
<sec>
<st>
Applications</st>

<ss1>
<st>
Chemical</st>
<p>

One of the first <link xlink:type="simple" xlink:href="../350/10772350.xml">
historical</link> QSAR applications was to predict <link xlink:type="simple" xlink:href="../115/4115.xml">
boiling point</link>s.<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%222%22])">2</ref></p>
<p>

It is well known for instance that within a particular <link xlink:type="simple" xlink:href="../136/4390136.xml">
family</link> of <link xlink:type="simple" xlink:href="../412/144412.xml">
chemical compound</link>s, especially of <link xlink:type="simple" xlink:href="../208/22208.xml">
organic chemistry</link>, that there are strong <link xlink:type="simple" xlink:href="../057/157057.xml">
correlation</link>s between structure and observed properties. A simple example is the relationship between the number of carbons in <link xlink:type="simple" xlink:href="../639/639.xml">
alkanes</link> and their <link xlink:type="simple" xlink:href="../115/4115.xml">
boiling point</link>s. There is a clear trend in the increase of boiling point with an increase in the number carbons and this serves as a means for predicting the boiling points of <link xlink:type="simple" xlink:href="../639/639.xml">
higher alkanes</link>.</p>
<p>

A still very interesting application is the <link xlink:type="simple" xlink:href="../733/4986733.xml">
Hammett equation</link>, <link xlink:type="simple" xlink:href="../857/14485857.xml">
Taft equation</link> and <link xlink:type="simple" xlink:href="../555/57555.xml">
pKa prediction</link> methods.<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%223%22])">3</ref></p>

</ss1>
<ss1>
<st>
Biological</st>
<p>

The biological activity of molecules is usually measured in <link xlink:type="simple" xlink:href="../309/496309.xml">
assay</link>s to establish the level of inhibition of particular <link xlink:type="simple" xlink:href="../857/28857.xml">
signal transduction</link> or <link xlink:type="simple" xlink:href="../941/20941.xml">
metabolic pathway</link>s. Chemicals can also be biologically active by being <link xlink:type="simple" xlink:href="../567/170567.xml">
toxic</link>.  <link xlink:type="simple" xlink:href="../274/571274.xml">
Drug discovery</link> often involves the use of QSAR to identify chemical structures that could have good inhibitory effects on specific <link xlink:type="simple" xlink:href="../065/1504065.xml">
targets</link> and have low <link xlink:type="simple" xlink:href="../567/170567.xml">
toxicity</link> (non-specific activity).  Of special interest is the prediction of <link xlink:type="simple" xlink:href="../652/796652.xml">
partition coefficient</link> log <it>P</it>, which is an important measure used in identifying "<link xlink:type="simple" xlink:href="../249/10856249.xml">
druglikeness</link>" according to <link xlink:type="simple" xlink:href="../713/826713.xml">
Lipinski's Rule of Five</link>. </p>
<p>

While many quantitative structure activity relationship analyses involve the interactions of a family of molecules with an <link xlink:type="simple" xlink:href="../257/9257.xml">
enzyme</link> or <link xlink:type="simple" xlink:href="../480/569480.xml">
receptor</link> binding site, QSAR can also be used to study the interactions between the <link xlink:type="simple" xlink:href="../725/10130725.xml">
structural domain</link>s of proteins. Protein-protein interactions can be quantitatively analyzed for structural variations resulted from <link xlink:type="simple" xlink:href="../361/564361.xml">
site-directed mutagenesis</link>.<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%224%22])">4</ref>.</p>
<p>

It is part of the <link xlink:type="simple" xlink:href="../488/233488.xml">
machine learning</link> method to reduce the risk for a SAR paradox, especially taking into account that only a finite amount of data is available (see also <link xlink:type="simple" xlink:href="../470/1583470.xml">
MVUE</link>). In general all QSAR problems can be divided into a <link xlink:type="simple" xlink:href="../892/40892.xml">
coding</link><ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%225%22])">5</ref> and <link xlink:type="simple" xlink:href="../403/183403.xml">
learning</link><ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%226%22])">6</ref> part.</p>

</ss1>
<ss1>
<st>
Data mining</st>
<p>

For the coding usually a relatively large number of features or molecular descriptors is calculated, which can lack structural interpretation ability. In combination with the later applied learning method or as preprocessing step occurs a <link xlink:type="simple" xlink:href="../950/1179950.xml">
feature selection</link> problem. </p>
<p>

A typical <link xlink:type="simple" xlink:href="../253/42253.xml">
data mining</link> based prediction uses e.g. <link xlink:type="simple" xlink:href="../309/65309.xml">
support vector machine</link>s, <link xlink:type="simple" xlink:href="../602/232602.xml">
decision tree</link>s, <link>
neural networks</link> for <link xlink:type="simple" xlink:href="../736/393736.xml">
inducing</link> a predictive learning model.</p>

<ss2>
<st>
3D-QSAR</st>
<p>

<b>3D-QSAR</b> refers to the application of <power wordnetid="105190804" confidence="0.8">
<influence wordnetid="105194151" confidence="0.8">
<force wordnetid="105194578" confidence="0.8">
<link xlink:type="simple" xlink:href="../615/2916615.xml">
force field</link></force>
</influence>
</power>
 calculations requiring three-dimensional structures, e.g. based on protein <link xlink:type="simple" xlink:href="../794/7794.xml">
crystallography</link> or molecule <link>
superposition</link>. It uses computed potentials, e.g. the <power wordnetid="105190804" confidence="0.8">
<influence wordnetid="105194151" confidence="0.8">
<force wordnetid="105194578" confidence="0.8">
<link xlink:type="simple" xlink:href="../686/227686.xml">
Lennard-Jones potential</link></force>
</influence>
</power>
, rather than experimental constants and is concerned with the overall molecule rather than a single substituent. It examines the steric fields (shape of the molecule) and the electrostatic fields based on the applied energy function.<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%227%22])">7</ref></p>
<p>

The created data space is then usually reduced by a following <link xlink:type="simple" xlink:href="../190/242190.xml">
feature extraction</link> (see also <link xlink:type="simple" xlink:href="../867/579867.xml">
dimensionality reduction</link>). The following learning method can be any of the already mentioned <link xlink:type="simple" xlink:href="../488/233488.xml">
machine learning</link> methods, e.g. <link xlink:type="simple" xlink:href="../309/65309.xml">
support vector machine</link>s.<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%228%22])">8</ref></p>
<p>

In the literature it can be often found that chemists have a preference for <link xlink:type="simple" xlink:href="../736/1046736.xml">
partial least squares</link> (PLS) methods, since  it applies the <link xlink:type="simple" xlink:href="../190/242190.xml">
feature extraction</link> and <link xlink:type="simple" xlink:href="../736/393736.xml">
induction</link> in one step.</p>

</ss2>
</ss1>
<ss1>
<st>
Molecule mining</st>
<p>

<link xlink:type="simple" xlink:href="../611/4851611.xml">
Molecule mining</link> approaches, a special case of <link xlink:type="simple" xlink:href="../545/4851545.xml">
structured data mining</link> approaches, apply a similarity matrix based prediction or an automatic fragmentation scheme into molecular substructures. Furthermore there exist also approaches using <condition wordnetid="113920835" confidence="0.8">
<state wordnetid="100024720" confidence="0.8">
<problem wordnetid="114410605" confidence="0.8">
<difficulty wordnetid="114408086" confidence="0.8">
<link xlink:type="simple" xlink:href="../963/4288963.xml">
maximum common subgraph</link></difficulty>
</problem>
</state>
</condition>
 searches or <link>
graph kernel</link>s.<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%229%22])">9</ref>
<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2210%22])">10</ref></p>

<ss2>
<st>
Fragment based (group contribution)</st>
<p>

It has been shown that the <link xlink:type="simple" xlink:href="../807/4612807.xml">
logP</link> of compound can be determined by the sum of its fragments. Fragmentary logP values have been determined statistically. This method gives mixed results and is generally not trusted to have accuracy of more than +/- 0.1 units.<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2211%22])">11</ref></p>

</ss2>
</ss1>
</sec>
<sec>
<st>
 Applicability Domain </st>
<p>

As the use of (Q)SAR models for chemical risk management increases steadily and is also used for regulatory purposes (in the EU: <link xlink:type="simple" xlink:href="../665/1301665.xml">
Registration, Evaluation, Authorisation and Restriction of Chemicals</link>), it is of crucial importance to be able to assess the reliability of predictions. The chemical descriptor space spanned by a particular training set of chemicals is called <link xlink:type="simple" xlink:href="../713/13629713.xml">
Applicability Domain</link>. It offers the opportunity to assess whether a compound can be reliably predicted.</p>

</sec>
<sec>
<st>
See also</st>
<p>

<list>
<entry level="1" type="bullet">

<link xlink:type="simple" xlink:href="../697/4387697.xml">
Structure-activity relationship</link></entry>
<entry level="1" type="bullet">

<link xlink:type="simple" xlink:href="../697/575697.xml">
Cheminformatics</link></entry>
<entry level="1" type="bullet">

<link xlink:type="simple" xlink:href="../690/826690.xml">
ADME</link></entry>
<entry level="1" type="bullet">

<link xlink:type="simple" xlink:href="../652/796652.xml">
Differential solubility</link></entry>
<entry level="1" type="bullet">

<link xlink:type="simple" xlink:href="../417/15417.xml">
Intermolecular force</link></entry>
<entry level="1" type="bullet">

<link xlink:type="simple" xlink:href="../107/9674107.xml">
Pharmacokinetics</link></entry>
<entry level="1" type="bullet">

<link xlink:type="simple" xlink:href="../359/1078359.xml">
Pharmacophore</link></entry>
<entry level="1" type="bullet">

<link xlink:type="simple" xlink:href="../652/796652.xml">
CLogP</link></entry>
<entry level="1" type="bullet">

<link xlink:type="simple" xlink:href="../414/579414.xml">
Computer-assisted drug design</link> (CADD)</entry>
<entry level="1" type="bullet">

<know-how wordnetid="105616786" confidence="0.8">
<method wordnetid="105660268" confidence="0.8">
<link xlink:type="simple" xlink:href="../769/306769.xml">
Protein structure prediction</link></method>
</know-how>
</entry>
<entry level="1" type="bullet">

<periodical wordnetid="106593296" confidence="0.9508927676800064">
<link xlink:type="simple" xlink:href="../675/5350675.xml">
QSAR &amp; Combinatorial Science</link></periodical>
 - <link xlink:type="simple" xlink:href="../316/37316.xml">
Scientific journal</link></entry>
<entry level="1" type="bullet">

<link xlink:type="simple" xlink:href="../850/12207850.xml">
Software for molecular mechanics modeling</link></entry>
</list>
</p>

</sec>
<sec>
<st>
References</st>
<p>

<reflist>
<entry id="1">
G. A. Patani, E. J. LaVoie, <it>Bioisosterism: A Rational Approach in Drug Design</it>. Chem. Rev., 1996, 96, 3147-3176. <document wordnetid="106470073" confidence="0.8">
<written_communication wordnetid="106349220" confidence="0.8">
<writing wordnetid="106362953" confidence="0.8">
<link xlink:type="simple" xlink:href="../994/422994.xml">
doi</link></writing>
</written_communication>
</document>
:<weblink xlink:type="simple" xlink:href="http://dx.doi.org/10.1021%2Fcr950066q">
10.1021/cr950066q</weblink></entry>
<entry id="2">
<link>
Danail Bonchev</link>, D.H. Rouvray: <it><link xlink:type="simple" xlink:href="../708/14222708.xml">
Chemical Graph Theory</link>: Introduction and Fundamentals</it>. Gordon and Breach Science Publishers, 1990, ISBN 0-85626-454-7.</entry>
<entry id="3">
 <cite style="font-style:normal">Fraczkiewicz, R&#32;(2007). "In Silico Prediction of Ionization".&#32;Testa B and van de Waterbeemd H, eds.&#32;<it>Comprehensive Medicinal Chemistry II</it>&#32;<b>vol. 5</b>, Amsterdam, The Netherlands:&#32;Elsevier.</cite>&nbsp;</entry>
<entry id="4">
E. K. Freyhult, K. Andersson, M. G. Gustafsson, <it>Structural modeling extends QSAR analysis of antibody-lysozyme interactions to 3D-QSAR</it>,J. Biophys., <b>2003</b>,  <it>84</it>, <symbol wordnetid="106806469" confidence="0.8">
<standard wordnetid="107260623" confidence="0.8">
<signal wordnetid="106791372" confidence="0.8">
<identifier wordnetid="107270601" confidence="0.8">
<system_of_measurement wordnetid="113577171" confidence="0.8">
<link xlink:type="simple" xlink:href="../930/234930.xml">
ISSN</link></system_of_measurement>
</identifier>
</signal>
</standard>
</symbol>
 <weblink xlink:type="simple" xlink:href="http://worldcat.org/issn/2264-2272">
2264-2272</weblink>. PMID 12668435</entry>
<entry id="5">
 <link>
Roberto Todeschini</link>, <link>
Viviana Consonni</link>, <it>Handbook of Molecular Descriptors</it>, Wiley-VCH, <b>2000</b>. ISBN 3527299130</entry>
<entry id="6">
R.O. Duda, P.E. Hart, D.G. Stork, <it>Pattern Classification</it>, John Wiley &amp; Sons, <b>2001</b>. ISBN 0-471-05669-3</entry>
<entry id="7">
A. Leach, <it>Molecular Modelling: Principles and Applications</it>, Prentice Hall, <b>2001</b>. ISBN 0-582-38210-6</entry>
<entry id="8">
Schölkopf, B., K. Tsuda and J. P. Vert: <it>Kernel Methods in Computational Biology</it>, MIT Press, Cambridge, MA, <b>2004</b>.</entry>
<entry id="9">
Gusfield, D., <it>Algorithms on Strings, Trees, and Sequences: Computer Science and Computational Biology</it>, Cambridge University Press, <b>1997</b>. ISBN 0-521-58519-8</entry>
<entry id="10">
C. Helma (ed.), <it>Predictive Toxicology</it>, CRC, <b>2005</b>. ISBN 0-8247-2397-X</entry>
<entry id="11">
S. A. Wildman, G. M. Crippen, <it>Prediction of Physicochemical Parameters by Atomic Contributions</it>, J. Chem. Inf. Comput. Sci.}, <b>1999</b>, <it>39</it>, 868-873. <document wordnetid="106470073" confidence="0.8">
<written_communication wordnetid="106349220" confidence="0.8">
<writing wordnetid="106362953" confidence="0.8">
<link xlink:type="simple" xlink:href="../994/422994.xml">
doi</link></writing>
</written_communication>
</document>
:<weblink xlink:type="simple" xlink:href="http://dx.doi.org/10.1021%2Fci990307l">
10.1021/ci990307l</weblink></entry>
</reflist>
</p>

</sec>
<sec>
<st>
External links</st>
<p>

<list>
<entry level="1" type="bullet">

 <weblink xlink:type="simple" xlink:href="http://www.qsarworld.com">
QSAR World - A comprehensive web resource for QSAR modelers</weblink></entry>
<entry level="1" type="bullet">

 <weblink xlink:type="simple" xlink:href="http://media.wiley.com/product_data/excerpt/03/04712709/0471270903.pdf">
History of QSAR</weblink> - (<link xlink:type="simple" xlink:href="../077/24077.xml">
PDF</link>)</entry>
<entry level="1" type="bullet">

 <weblink xlink:type="simple" xlink:href="http://www.natureprotocols.com/2007/03/05/development_of_qsar_models_usi_1.php">
Development of QSAR models using C-QSAR program: a regression program that has dual databases of over 21,000 QSAR models (a protocol)</weblink></entry>
<entry level="1" type="bullet">

<weblink xlink:type="simple" xlink:href="http://www.syrres.com/qsar2008">
 The 13th International Workshop on Quantitative Structure-Activity Relationships (QSARs) in the Environmental Sciences</weblink></entry>
<entry level="1" type="bullet">

<weblink xlink:type="simple" xlink:href="http://www.qsar.org/">
The Cheminformatics and QSAR Society</weblink> </entry>
</list>
</p>

<p>

<table style=";" class="navbox" cellspacing="0">
<row>
<col style="padding:2px;">
<table style="width:100%;background:transparent;color:inherit;;" class="nowraplinks collapsible autocollapse " cellspacing="0">
<row>
<header colspan="2" style=";" class="navbox-title">
Topics in <link xlink:type="simple" xlink:href="../177/938177.xml">
Medicinal Chemistry</link></header>
</row>
<row style="height:2px;">

</row>
<row>
<col colspan="2" style="width:100%;padding:0px;;;" class="navbox-list navbox-odd">
<link xlink:type="simple" xlink:href="../690/826690.xml">
ADME</link>&nbsp;·  <link xlink:type="simple" xlink:href="../021/769021.xml">
Bioavailability</link>&nbsp;·  <link xlink:type="simple" xlink:href="../909/5168909.xml">
Chemogenomics</link>&nbsp;·  <link xlink:type="simple" xlink:href="../414/579414.xml">
Drug design</link>&nbsp;·  <link xlink:type="simple" xlink:href="../274/571274.xml">
Drug discovery</link>&nbsp;·  <link xlink:type="simple" xlink:href="../960/5464960.xml">
Enzyme inhibitor</link>&nbsp;·  <link xlink:type="simple" xlink:href="../731/5105731.xml">
Mechanism of action</link>&nbsp;·  <link xlink:type="simple" xlink:href="../454/1775454.xml">
New chemical entity</link>&nbsp;·  <link xlink:type="simple" xlink:href="../049/726049.xml">
Pharmacodynamics</link>&nbsp;·  <link xlink:type="simple" xlink:href="../107/9674107.xml">
Pharmacokinetics</link>&nbsp;·  <link xlink:type="simple" xlink:href="../354/24354.xml">
Pharmacology</link>&nbsp;·  <link xlink:type="simple" xlink:href="../359/1078359.xml">
Pharmacophore</link>&nbsp;·  <link xlink:type="simple" xlink:href="../669/826669.xml">
Quantitative structure-activity relationship</link></col>
</row>
</table>
</col>
</row>
</table>
</p>




</sec>
</bdy>
</entity>
</article>
